[The terminal complement complex (TCC)--a mediator in the development of disease in man?]
- PMID: 1994560
[The terminal complement complex (TCC)--a mediator in the development of disease in man?]
Abstract
Activation of the terminal complement pathway leads to the formation of the terminal complement complexes (TCC). TCC exists in one active membrane form, C5b-9 and in one inactive fluid phase form, SC5b-9. The paper explores the structure and regulatory mechanisms of TCC. In addition, methods of detecting TCC in tissue and in biological fluids, guidelines for sampling and the importance of TCC as an inflammatory mediator in human disease are discussed.
Similar articles
-
Terminal complement complex (TCC) and S-protein (vitronectin) on follicular dendritic cells in human lymphoid tissues.Immunology. 1988 Oct;65(2):193-7. Immunology. 1988. PMID: 2461343 Free PMC article.
-
Relative inefficiency of terminal complement activation.J Immunol. 1988 Nov 1;141(9):3117-22. J Immunol. 1988. PMID: 3262681
-
Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.Mol Immunol. 2009 Feb;46(4):688-94. doi: 10.1016/j.molimm.2008.09.001. Epub 2008 Oct 31. Mol Immunol. 2009. PMID: 18950866
-
[The complement system as a mediator of acute inflammation].Dtsch Tierarztl Wochenschr. 1983 Sep 8;90(9):374-7. Dtsch Tierarztl Wochenschr. 1983. PMID: 6354683 Review. German. No abstract available.
-
[The complement system--structure, activation, regulation and function].Tidsskr Nor Laegeforen. 1999 Jan 20;119(2):226-33. Tidsskr Nor Laegeforen. 1999. PMID: 10081355 Review. Norwegian.